CA Patent

CA2413033A1 — Near infrared fluorescent contrast agent and fluorescence imaging

Assigned to Bayer Pharma AG · Expires 2000-03-30 · 26y expired

What this patent protects

Disclosed is the sodium salt having the formula: (See formula I:) and a near infrared fluorescent contrast agent comprising the above compound.

USPTO Abstract

Disclosed is the sodium salt having the formula: (See formula I:) and a near infrared fluorescent contrast agent comprising the above compound.

Drugs covered by this patent

Patent Metadata

Patent number
CA2413033A1
Jurisdiction
CA
Classification
Expires
2000-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.